Springfield, NJ, United States of America

Thea Kalebic

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thea Kalebic: Innovator in Leukemia Treatment

Introduction

Thea Kalebic is a notable inventor based in Springfield, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of Philadelphia-positive leukemia. Her innovative approach has the potential to improve the lives of many patients suffering from this condition.

Latest Patents

Thea Kalebic holds a patent for a method of optimizing the treatment of Philadelphia-positive leukemia with imatinib mesylate. This invention specifically addresses the treatment of chronic myeloid leukemia (CML) in human patients. The method involves a series of steps designed to enhance the effectiveness of the treatment for those suffering from Ph+ leukemia.

Career Highlights

Throughout her career, Thea has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Medvet Science Pty Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of leukemia treatment.

Collaborations

Thea has collaborated with esteemed colleagues such as Yanfeng Wang and Timothy P. Hughes. These partnerships have contributed to her success and the advancement of her research in leukemia treatment.

Conclusion

Thea Kalebic is a pioneering inventor whose work in optimizing leukemia treatment showcases her dedication to improving patient outcomes. Her contributions to the medical field are invaluable and highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…